KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Other Operating Expenses (2017 - 2026)

Teva Pharmaceutical Industries filings provide 11 years of Other Operating Expenses readings, the most recent being $9.0 million for Q1 2026.

  • On a quarterly basis, Other Operating Expenses rose 280.0% to $9.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$5.0 million, a 150.0% decrease, with the full-year FY2025 number at -$18.0 million, down 228.57% from a year prior.
  • Other Operating Expenses hit $9.0 million in Q1 2026 for Teva Pharmaceutical Industries, up from -$3.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $52.0 million in Q1 2022 to a low of -$8.0 million in Q4 2024.
  • Median Other Operating Expenses over the past 5 years was $2.0 million (2022), compared with a mean of $9.5 million.
  • Biggest five-year swings in Other Operating Expenses: skyrocketed 940.0% in 2022 and later plummeted 400.0% in 2025.
  • Teva Pharmaceutical Industries' Other Operating Expenses stood at $19.0 million in 2022, then plummeted by 68.42% to $6.0 million in 2023, then tumbled by 233.33% to -$8.0 million in 2024, then soared by 62.5% to -$3.0 million in 2025, then surged by 400.0% to $9.0 million in 2026.
  • The last three reported values for Other Operating Expenses were $9.0 million (Q1 2026), -$3.0 million (Q4 2025), and -$7.0 million (Q3 2025) per Business Quant data.